Search

Search Constraints

You searched for: Author/Creator Kanellopoulos, Alexandros

Search Results

1. Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant Center. (14th August 2020)

2. Central nervous system involvement in primary bone marrow or splenic marginal zone lymphoma: Report of two cases and review of the literature. Issue 2 (1st February 2019)

3. COVID‐19 in bone marrow transplant recipients: reflecting on a single centre experience. (23rd June 2020)

5. Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations. (22nd January 2021)

6. Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation. Issue 1 (2nd January 2020)

7. Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens. (26th February 2016)

8. Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens. (26th February 2016)

9. Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience. Issue 12 (15th October 2019)

10. Reduced‐intensity conditioning allogeneic transplantation after salvage treatment with DT‐PACE in myeloma patients relapsing early after autologous transplant. (20th July 2017)